Sanjiv Kumar

Sanjiv Kumar

Auto-generated profile, based on publicly available information

Sanjiv Kumar

Chaudhary Bansi Lal Univ, Dept Pharmaceut Sci, Bhiwani 127021, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
NSNeetu Singh
Neetu Singh
SYSurender Singh Yadav
Surender Singh Yadav
SKSanjiv Kumar
Sanjiv Kumar
BNBalasubramaniam Narashiman
Balasubramaniam Narashiman

18 September 2017 in BMC Chemistry
Verified
Journal Article
Open access
PDF file
SKSanjiv Kumar
Sanjiv Kumar
SLSiong Meng Lim
Siong Meng Lim
KRKalavathy Ramasamy
Kalavathy Ramasamy
Vasudevan ManiVasudevan Mani
Vasudevan Mani
SSSyed Adnan Ali Shah
Syed Adnan Ali Shah
BNBalasubramanian Narasimhan
Balasubramanian Narasimhan
Heterocyclic pyrimidine nucleus, which is an essential base component of the genetic material of deoxyribonucleic acid, demonstrated various biological activities. A series of bis-pyrimidine Schiff bases were synthesized and screened for its antimicrobial and anticancer potentials. The molecular docking study was carried to find the interaction between active molecules with receptor. The structures of synthesized bis-pyrimidine Schiff bases were confirmed by spectral studies. The synthesized bis-pyrimidine derivatives were evaluated for their antimicrobial activity (MIC = µmol/mL) against selected Gram positive; Gram negative bacterial and fungal strains by tube dilution method. The anticancer activity (IC50 = µmol/mL) of the synthesized compounds was determined against human colorectal carcinoma (HCT116) cancer cell line by Sulforhodamine B (SRB) assay. Molecular docking studies provided information regarding the binding mode of active bis-pyrimidine Schiff bases with the cyclin-dependent kinase 8 (CDK8) receptor. The antimicrobial screening results indicated that compounds, q1 (MICbs = 0.83 µmol/mL), q16 (MICan = 1.54 µmol/mL and MICec = 0.77 µmol/mL), q1 and q19 (MICca = 0.41 µmol/mL) and q20 (MIC = 0.36 µmol/mL) are the most active ones. Compounds q1 (IC50 = 0.18 µmol/mL) have emerged as potent anticancer molecule against human colorectal carcinoma cancer cell line than the reference drug, 5-fluorouracil. Molecular docking studies indicated that compound q1 (the most active molecule) has the maximum hydrogen bond interaction (four) and π–π stacking (three) network among the bis-pyrimidine Schiff bases.

11 January 2021 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
SNSangeeta Narwal
Sangeeta Narwal
SKSanjiv Kumar
Sanjiv Kumar
PVPrabhakar Kumar Verma
Prabhakar Kumar Verma

13 January 2010 in Vascular Pharmacology
Verified
Journal Article
Open access
CXChenling Xiong
Chenling Xiong
GYGuang Yang
Guang Yang
SKSanjiv Kumar
Sanjiv Kumar
SASaurabh Aggarwal
Saurabh Aggarwal
MLMartin Leustik
Martin Leustik
RLRudolf Lucas
Rudolf Lucas
Listeriosis can lead to potentially lethal pulmonary complications in newborns and immune compromised patients, characterized by extensive permeability edema. Listeriolysin (LLO), the main virulence factor of Listeria monocytogenes, induces a dose-dependent hyperpermeability in monolayers of human lung microvascular endothelial cells in vitro. The permeability increasing activity of LLO, which is accompanied by an increased reactive oxygen species (ROS) generation, RhoA activation and myosin light chain (MLC) phosphorylation, can be completely inhibited by the protein kinase C (PKC) α/β inhibitor GÖ6976, indicating a crucial role for PKC in the induction of barrier dysfunction. The TNF-derived TIP peptide, which mimics the lectin-like domain of the cytokine, blunts LLO-induced hyperpermeability in vitro, upon inhibiting LLO-induced protein kinase C-α activation, ROS generation and MLC phosphorylation and upon restoring the RhoA/Rac 1 balance. These results indicate that the lectin-like domain of TNF has a potential therapeutic value in protecting from LLO-induced pulmonary endothelial hyperpermeability.

1 December 2007 in DNA and Cell Biology
Verified
Journal Article
Closed access
SKSanjiv Kumar
Sanjiv Kumar
SWStephen Wedgwood
Stephen Wedgwood
SBStephen M Black
Stephen M Black
It has been previously reported that the antioxidant compound nordihydroguaiaretic acid (NDGA) increases endothelial nitric oxide synthase (eNOS) expression in cultured bovine aortic endothelial cells. However, the exact mechanism for this effect was unresolved. Thus, the purpose of this study was to further elucidate the effect of NDGA on eNOS protein expression and enzymatic activity in fetal pulmonary arterial endothelial cells (FPAECs), and to identify the transcription factors involved in this regulation. Following overnight exposure to 0–32 μM NDGA, we observed a 2- to 2.5-fold increase in eNOS protein expression in FPAECs, with a similar increase observed in eNOS activity. For eNOS gene promoter analysis, we initially used two promoter–reporter constructs: a 1.6 kb promoter fragment and an 840 bp construct, both of which include an AP-1–specific binding site. NDGA exposure induced a significant increase in eNOS promoter activity in both constructs. However, the NDGA-mediated increase was abolished when we used either a truncated promoter construct lacking the AP-1 element or a construct in which the AP-1 binding site was mutated. AP-1 binding efficiency was also determined by electrophoretic mobility shift assay, where we observed an increase in AP-1 binding in FPAECs treated with NDGA while the binding of AP-1 was found to be decreased when a mutated AP-1 consensus sequence was used. Further, supershift analyses indicated that the AP-1 complex consisted of c-Jun and FosB. We therefore conclude that NDGA antioxidant activity regulates eNOS expression via AP-1 and that antioxidant therapy could potentially be used to increase eNOS expression in diseases, such as persistent pulmonary hypertension of the newborn, where eNOS expression and activity are known to be reduced.

1 January 2024
Verified
Journal Article
Closed access
RRRahul Rawat
Rahul Rawat
HKHarish Kumar
Harish Kumar
NSNeetu Singh
Neetu Singh
ADAakash Deep
Aakash Deep
BNBalasubramanian Narasimhan
Balasubramanian Narasimhan
SKSanjiv Kumar
Sanjiv Kumar